Scribd
Upload
171 views1 page

Mangalam Drugs Report

Mangalam Drugs and Organics Ltd, an Indian pharmaceutical company, has informed stock exchanges that it has successfully developed the active pharmaceutical ingredient (API) Favipiravir, which is being studied as a potential treatment for COVID-19. The company will start commercial production of Favipiravir API once it receives approval from the FDA and the Government of India for use in treating COVID-19. Mangalam Drugs is committed to research and development efforts and hopes this new API will help address the COVID-19 pandemic.

Uploaded by

BKS
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
171 views1 page

Mangalam Drugs Report

Mangalam Drugs and Organics Ltd, an Indian pharmaceutical company, has informed stock exchanges that it has successfully developed the active pharmaceutical ingredient (API) Favipiravir, which is being studied as a potential treatment for COVID-19. The company will start commercial production of Favipiravir API once it receives approval from the FDA and the Government of India for use in treating COVID-19. Mangalam Drugs is committed to research and development efforts and hopes this new API will help address the COVID-19 pandemic.

Uploaded by

BKS
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

A,

wttrw
-wrr, -
\lv
!r
Mangslam Drugs and Organics Ltd. ^-.
MANCALAM
\-
,- Regd. Office : Rupam Building, 3rd Floor, 239 P. D'Mello Road, Near G. P. O. Mumbai - 400 001.
WHO.GMP
@ 9I-22-226L6200 / 6300 / 8787 @9L-72-22619090 o CIN : 124230MH1972PLC!1,64!3

REF: M D O U CS -SE/ 20 20 -2'1,/ 005 lune trL,2020


To,
Listing Department I-isting Departrnent
BSE Ltd National Stock Exchange of India
1't Floor, New Trade Wing, Limited
Phiroze Jeejeebhoy Towers, "Exchang e Plaza", 5e Floor,
Dalal Street, Fort, Plot No. C-L, Block G,
Mumbai - 400 001 Bandra - Kurla Complex,
Bandra(E), Mumbai - 400 051

Scrip Code: 532637 Symbol MANGALAM

Sub: Update on development of API Favipiravir

Dear Sir/Madam,

Mangalam Drugs and Organics Limited (the Company) is inter-alia engaged in the
business of manufacturing of various Active Pharmaceutical Ingredient (APIs).

The Company is constantly committed to perform healthy R&D as a result of whiclu


the Company have successfully developed the API Favipiravir which is being
advised for the treatment of COVID - L9.

Once the Favipiravir API is approved by Food and Drug Adminiskation (FDA) and
the Government of India as a treatment of COVID-19, the Company will start
production of the same and offer commercially in the market.

Kindly take the above update on your records.

Thanking you,

Yours faithfully,
For Mangalam Drugs & Organics Limited

ffi"$
Geeta Karira
Sw9
Company Secretary & Compliance Officer

Factory : at Vapi (Gujarat) India @ contactus@mangalamdrugs.com @ http://www.mangalarndrugs.com

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy